首页> 外文期刊>The Journal of Urology >Combining hand assisted laparoscopic nephroureterectomy with cystoscopic circumferential excision of the distal ureter without primary closure of the bladder cuff--is it safe?
【24h】

Combining hand assisted laparoscopic nephroureterectomy with cystoscopic circumferential excision of the distal ureter without primary closure of the bladder cuff--is it safe?

机译:将手辅助腹腔镜肾结直肠癌切除术与输尿管远端膀胱镜下圆周切除术相结合,而无需首先闭合膀胱套囊,是否安全?

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We have previously described our technique of combining HAL-NU using early ureteral ligation with simultaneous cystoscopic circumferential excision of the distal intramural ureter without primary closure of the bladder cuff. We report the oncological sequelae in patients who underwent HAL-NU using our technique of complete ureteral removal. MATERIALS AND METHODS: We retrospectively evaluated all patients who underwent HAL-NU from April 1999 through July 2004. Cystograms were performed 1 week postoperatively in all patients. Pathological findings were reviewed. Cystoscopy was performed every 3 months to assess bladder recurrences. Upper tract imaging was performed postoperatively and then annually. The locations of recurrence and need for adjuvant treatment were assessed. RESULTS: A total of 49 patients with an average age of 67 years underwent HAL-NU. Gravity cystography confirmed that bladder defects had completely sealed at 1 week in all patients. Mean followup was 10.6 months (median 10, range 1 to 52). Of the patients 20 (49%) had bladder tumors postoperatively. Two patients were found to have advanced stage disease, leading to chemotherapy with radiation therapy in 1 and radical cystectomy in the other at 4 and 14 months, respectively. A total of 25 patients had postoperative pelvic imaging. Four patients with pathological stage T2 (1) and T3 (3) had metastatic disease at followup. One patient was known to have pulmonary metastases preoperatively and HAL-NU was performed for refractory hematuria. Two patients were noted to have distant metastases to the liver, lung and bone at 1 and 3 months postoperatively, respectively. One patient was found to have distant metastases to the liver and retroperitoneal lymph nodes 2 years after surgery. No patients were found to have local pelvic or peritoneal metastases. CONCLUSIONS: HAL-NU with cystoscopic excision of the distal ureter is feasible, safe and effective for upper tract transitional cell carcinoma. Oncological sequelae are comparable to results after open surgery. There is no evidence to suggest pelvic or peritoneal tumor seeding since no cases of pelvic or abdominal recurrence were discovered after surgery, while allowing the bladder defect to close spontaneously with catheter drainage. Our technique of ureterectomy ensures complete removal of the entire ureter, eliminating the possibility of ureteral stump recurrences. Early ligation of the ureter prevents tumor migration during renal manipulation, minimizing the risk of local tumor recurrences postoperatively.
机译:目的:我们先前已经描述了使用早期输尿管结扎术结合HAL-NU并同时进行膀胱壁远端输尿管内膀胱镜周向切除术而没有首先闭合膀胱套的技术。我们报告了使用我们的完全输尿管切除技术对接受过HAL-NU治疗的患者的肿瘤后遗症。材料与方法:我们回顾性评估了从1999年4月至2004年7月接受HAL-NU治疗的所有患者。所有患者术后1周进行了膀胱造影。病理结果进行了审查。每3个月进行一次膀胱镜检查以评估膀胱复发情况。术后进行上道成像,然后每年进行一次。评估了复发的位置和需要进行辅助治疗。结果:总共49例平均年龄为67岁的患者接受了HAL-NU治疗。重力膀胱造影证实所有患者的膀胱缺损均在1周时完全闭合。平均随访10.6个月(中位数10,范围1至52)。在这些患者中,有20名(49%)术后患有膀胱肿瘤。发现两名患者患有晚期疾病,分别在4个月和14个月时分别进行了放射治疗和1例行根治性膀胱切除术的化疗。共有25例患者术后进行了骨盆成像。病理分期为T2(1)和T3(3)的4例患者在随访时出现转移性疾病。已知一名患者术前有肺转移,并因难治性血尿进行了HAL-NU手术。注意到两名患者分别在术后1和3个月到肝,肺和骨有远处转移。术后2年发现一名患者远处转移至肝脏和腹膜后淋巴结。没有发现患者有局部骨盆或腹膜转移。结论:HAL-NU膀胱镜下输尿管远端切除术是可行,安全,有效的。肿瘤后遗症与开放手术后的结果相当。没有证据表明有盆腔或腹膜肿瘤播种,因为手术后未发现盆腔或腹部复发病例,同时允许膀胱引流通过导管引流自动闭合。我们的输尿管切除术可确保完全切除整个输尿管,消除了输尿管残端复发的可能性。输尿管的早期结扎可防止肿瘤在肾脏操作过程中迁移,从而将术后局部肿瘤复发的风险降至最低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号